Congresswoman Angie Craig Continues to Fight to Lower Skyrocketing Drug Costs

Bill to increase access to generic drugs passes out of House Judiciary Committee
May 1, 2019
Press Release

Today, the CREATES Act, which U.S. Rep. Angie Craig has cosponsored to lower the cost of prescription drugs, took one step closer to becoming law, as it was passed out of the House Judiciary Committee.

This bill would prohibit brand-name pharmaceutical companies’ current practice of blocking generic and biosimilar manufacturers from making more affordable, safe generic and biosimilar alternatives. The bill has strong bipartisan support and is backed by the AARP and Association for Accessible Medicines.

U.S. Rep. Angie Craig has heard from working families across the Second District who all say the same thing: when healthcare isn’t affordable, it isn’t accessible. That’s why she is working hard to pass this bill and other legislation that would find real solutions to lower healthcare costs for every family.

“I came to Congress to find real, common sense solutions to the skyrocketing healthcare costs that are putting the quality of life and access to life-saving medicine out of reach for too many Minnesotans,” said Rep. Craig. “This bill would take a critical step towards solving this problem by allowing more affordable generics to enter the market, and provide peace of mind for families struggling to afford their healthcare.”

Rep. Craig has made it a priority to address the burden of prescription drug costs by cosponsoring the following bills:

  • H.R. 478, the Safe and Affordable Drugs from Canada Act of 2019, which would allow consumers to import Food and Drug Administration-approved medications from Canada.
  • H.R. 938, the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, which is a bipartisan solution to remove a current 180-day block on bringing generic prescription drugs to the market.
  • H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019, which would end the unfair practice of brand-name drug companies paying to keep more affordable options off the market, commonly known as pay for delay.

In addition to cosponsoring the CREATES Act, Rep. Craig has introduced her own bill, the State Health Care Premium Reduction Act, to lower health insurance premiums in the individual market. That bill passed out of the Energy and Commerce Committee earlier this month.